Argentina
9 Vaccines Approved for Use in Argentina
RNA
Moderna
Spikevax
Approved in 86 countries
67 trials in 23 countries
Approval Source: saludneuquen.gob.ar
RNA
Pfizer/BioNTech
Comirnaty
Approved in 146 countries
84 trials in 27 countries
Approval Source: riotimesonline.com
Non Replicating Viral Vector
Non Replicating Viral Vector
Non Replicating Viral Vector
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 140 countries
64 trials in 31 countries
Approval Source: reuters.com
Non Replicating Viral Vector
Serum Institute of India
Covishield (Oxford/ AstraZeneca formulation)
Approved in 49 countries
4 trials in 1 country
Approval Source: batimes.com.ar
Inactivated
Sinopharm (Beijing)
Covilo
Approved in 91 countries
30 trials in 12 countries
Approval Source: xinhuanet.com
Inactivated
10 in Clinical Trials in Argentina
VLP
Medicago
Covifenz
Approved in 1 country
6 trials in 6 countries
RNA
Moderna
Spikevax
Approved in 86 countries
67 trials in 23 countries
RNA
Pfizer/BioNTech
Comirnaty
Approved in 146 countries
84 trials in 27 countries
Non Replicating Viral Vector
CanSino
Convidecia
Approved in 10 countries
13 trials in 6 countries
Non Replicating Viral Vector
Gamaleya
Sputnik Light
Approved in 26 countries
7 trials in 3 countries
Non Replicating Viral Vector
Gamaleya
Sputnik V
Approved in 74 countries
24 trials in 7 countries
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 140 countries
64 trials in 31 countries
Non Replicating Viral Vector
ReiThera
GRAd-COV2
5 trials in 12 countries
Inactivated
Sinopharm (Beijing)
Covilo
Approved in 91 countries
30 trials in 12 countries
1 Vaccines with Trials in Argentina are No Longer Progressing
RNA
Curevac
CVnCoV
9 trials in 12 countries